These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 15191391)
1. Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis. Rodríguez-Hernández MJ; Jiménez-Mejias ME; Pichardo C; Cuberos L; García-Curiel A; Pachón J Clin Microbiol Infect; 2004 Jun; 10(6):581-4. PubMed ID: 15191391 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972 [TBL] [Abstract][Full Text] [Related]
4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
5. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Garnacho-Montero J; Ortiz-Leyba C; Jiménez-Jiménez FJ; Barrero-Almodóvar AE; García-Garmendia JL; Bernabeu-WittelI M; Gallego-Lara SL; Madrazo-Osuna J Clin Infect Dis; 2003 May; 36(9):1111-8. PubMed ID: 12715304 [TBL] [Abstract][Full Text] [Related]
6. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates. Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052 [TBL] [Abstract][Full Text] [Related]
7. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070 [No Abstract] [Full Text] [Related]
8. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin. Pantopoulou A; Giamarellos-Bourboulis EJ; Raftogannis M; Tsaganos T; Dontas I; Koutoukas P; Baziaka F; Giamarellou H; Perrea D Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430 [TBL] [Abstract][Full Text] [Related]
11. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044 [TBL] [Abstract][Full Text] [Related]
12. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Michalopoulos A; Kasiakou SK; Rosmarakis ES; Falagas ME Scand J Infect Dis; 2005; 37(2):142-5. PubMed ID: 15764204 [TBL] [Abstract][Full Text] [Related]
13. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. Katragkou A; Roilides E J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177 [No Abstract] [Full Text] [Related]
15. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia. Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863 [TBL] [Abstract][Full Text] [Related]